Home
Vestal Point Capital reported a 6.5% stake in Enliven Therapeutics ELVN · 3,830,000 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 6.5%
- Last report
- First report
- Shares held
- 3,830,000 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Vestal Point Capital
- Event date
- 25/12/31
- Filed
- 26/02/17
First 5%+ report · 6.5% stake
Enliven Therapeutics trades, last 26 weeks
What else happened in Enliven Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Vestal Point Capital's other 5% stake reports
- Vestal Point Capital
5% stakeMonte Rosa Therapeutics
5% stakeMonte Rosa Therapeutics
GLUE
5.4% stake
4,600,000 sh
5.4% stake
Filed 08/14
- Vestal Point Capital
5% stakeMyriad Genetics
5% stakeMyriad Genetics
MYGN
6.1% stake
5,735,000 sh
6.1% stake
Filed 08/14
- Vestal Point Capital
5% stakeSolid Biosciences
5% stakeSolid Biosciences
SLDB
4.8% stake
4,833,796 sh
4.8% stake
Filed 08/14
- Vestal Point Capital
5% stakeImmunocore Holdings
5% stakeImmunocore Holdings
IMCR
3.5% stake
1,800,000 sh
3.5% stake
Filed 08/14
- Vestal Point Capital
5% stakeNurix Therapeutics
5% stakeNurix Therapeutics
NRIX
7.8% stake
8,050,000 sh
7.8% stake
Filed 08/14
